Projects per year
Abstract
Benzylic carbocations bearing an ortho- or para-hydroxyl group can be stabilized by forming quinone methides, which have been explored in enantioselective synthesis. However, those with a meta-hydroxyl group have remained almost unexplored in organic synthesis. The lack of resonance stabilization by a typical quinone methide form renders them not only difficult to generate, but also challenging to control for asymmetric bond formation. Here we report an efficient catalytic enantioselective reaction between meta-hydroxyl triarylmethanols and indoles, via triaryl carbocations, for the synthesis of tetraarylmethanes with excellent enantiocontrol. Control experiments reveal that the meta-hydroxyl group is essential for both reactivity and stereocontrol. Ortho-directing groups (alkoxyl, sulfenyl or fluoro) benefit enantiocontrol through secondary hydrogen-bonding interactions, but are not required for reactivity. The resulting tetraarylmethane products show anticancer activities, through a mechanism distinct from that of classical anticancer drugs. [Figure not available: see fulltext.]
© The Author(s), under exclusive licence to Springer Nature Limited2023
| Original language | English |
|---|---|
| Pages (from-to) | 275-285 |
| Number of pages | 11 |
| Journal | Nature Synthesis |
| Volume | 2 |
| Issue number | 3 |
| Online published | 16 Jan 2023 |
| DOIs | |
| Publication status | Published - Mar 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
RGC Funding Information
- RGC-funded
Fingerprint
Dive into the research topics of 'Enantioselective synthesis of tetraarylmethanes through meta-hydroxyl-directed benzylic substitution'. Together they form a unique fingerprint.Projects
- 3 Finished
-
GRF: Development and Biological Evaluation of Ultrasound-activatable Platinum(IV) Anticancer Prodrugs
ZHU, G. (Principal Investigator / Project Coordinator) & WANG, L. (Co-Investigator)
1/01/22 → 8/12/25
Project: Research
-
GRF: Photocaged Platinum Anticancer Prodrugs Targeting the Endoplasmic Reticulum to Conquer Drug Resistance
ZHU, G. (Principal Investigator / Project Coordinator)
1/09/20 → 7/08/24
Project: Research
-
GRF: Development and Mechanistic Investigation of Nucleus-targeting Platinum(IV) Prodrugs for Improved Anticancer Activity
ZHU, G. (Principal Investigator / Project Coordinator)
1/08/19 → 9/01/24
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver